Press-release for stocks for eyen

Prices are updated after-hours

| -81.43% | O: 0.68% H: 7.05% C: 3.69%
fda eye work submission mydcombi resubmission

Eyenovia Concludes Type A Meeting with FDA Related to MydCombi™ NDA Resubmission
Published: 2022-02-08 (Crawled : 18:00) - eyenoviabio.com
EYEN | $0.5501 0.07% 200K

| -81.43% | O: 0.68% H: 7.05% C: 3.69%
fda eye submission mydcombi resubmission

49%

51%

TPET | $0.503 117.66% 21M

JAGX | $0.23 93.6% 310M

WISA 4 | $3.22 84.0% 56M

SXTC | $2.56 82.86% 11M

PALI | $6.57 57.93% 19M

BTTR | $7.61 49.22% 1.8M

PRSO | $1.79 40.95% 38M

DYNT | $0.5203 40.47% 17M

MCBC | $13.755 38.52% 620K

SNGX | $0.51 32.09% 6.3M

Save your searches and get alerts when important news are released.